Placebo
MS200527-0018
Phase 2 small_molecule terminated
Quick answer
Placebo for Systemic Lupus Erythematosus is a Phase 2 program (small_molecule) at Serono Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Serono Europe Limited
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated